Testing for Exercise-Induced Bronchoconstriction

Research output: Contribution to journal › Review › Research › peer-review

Standard

Testing for Exercise-Induced Bronchoconstriction. / Brannan, John D.; Porsbjerg, Celeste.

In: Immunology and Allergy Clinics of North America, Vol. 38, No. 2, 2018, p. 215-229.

Research output: Contribution to journal › Review › Research › peer-review

Harvard

Brannan, JD & Porsbjerg, C 2018, 'Testing for Exercise-Induced Bronchoconstriction', Immunology and Allergy Clinics of North America, vol. 38, no. 2, pp. 215-229. https://doi.org/10.1016/j.iac.2018.01.010

APA

Brannan, J. D., & Porsbjerg, C. (2018). Testing for Exercise-Induced Bronchoconstriction. Immunology and Allergy Clinics of North America, 38(2), 215-229. https://doi.org/10.1016/j.iac.2018.01.010

Vancouver

Brannan JD, Porsbjerg C. Testing for Exercise-Induced Bronchoconstriction. Immunology and Allergy Clinics of North America. 2018;38(2):215-229. https://doi.org/10.1016/j.iac.2018.01.010

Author

Brannan, John D. ; Porsbjerg, Celeste. / Testing for Exercise-Induced Bronchoconstriction. In: Immunology and Allergy Clinics of North America. 2018 ; Vol. 38, No. 2. pp. 215-229.

Bibtex

@article{662769e7d3f348eb817e5a37e9697c91,
title = "Testing for Exercise-Induced Bronchoconstriction",
abstract = "Exercise-induced bronchoconstriction (EIB) is a form of airway hyperresponsiveness that occurs with or without current symptoms of asthma. EIB is an indicator of active and treatable pathophysiology in persons with asthma. The objective documentation of EIB permits the identification of an individual who may be at risk during a recreational sporting activity or when exercising as an occupational duty. EIB can be identified with laboratory exercise testing or surrogate tests for EIB. These include eucapnic voluntary hyperpnea and osmotic stimuli (eg, inhaled mannitol) and offer improved diagnostic sensitivity to identify EIB and improved standardization when compared with laboratory exercise.",
keywords = "Airway hyperresponsiveness, Eucapnic voluntary hyperpnea, Exercise-induced bronchoconstriction, Mannitol",
author = "Brannan, {John D.} and Celeste Porsbjerg",
year = "2018",
doi = "10.1016/j.iac.2018.01.010",
language = "English",
volume = "38",
pages = "215--229",
journal = "Immunology and Allergy Clinics of North America",
issn = "0889-8561",
publisher = "W.B.Saunders Co.",
number = "2",

}

RIS

TY - JOUR

T1 - Testing for Exercise-Induced Bronchoconstriction

AU - Brannan, John D.

AU - Porsbjerg, Celeste

PY - 2018

Y1 - 2018

N2 - Exercise-induced bronchoconstriction (EIB) is a form of airway hyperresponsiveness that occurs with or without current symptoms of asthma. EIB is an indicator of active and treatable pathophysiology in persons with asthma. The objective documentation of EIB permits the identification of an individual who may be at risk during a recreational sporting activity or when exercising as an occupational duty. EIB can be identified with laboratory exercise testing or surrogate tests for EIB. These include eucapnic voluntary hyperpnea and osmotic stimuli (eg, inhaled mannitol) and offer improved diagnostic sensitivity to identify EIB and improved standardization when compared with laboratory exercise.

AB - Exercise-induced bronchoconstriction (EIB) is a form of airway hyperresponsiveness that occurs with or without current symptoms of asthma. EIB is an indicator of active and treatable pathophysiology in persons with asthma. The objective documentation of EIB permits the identification of an individual who may be at risk during a recreational sporting activity or when exercising as an occupational duty. EIB can be identified with laboratory exercise testing or surrogate tests for EIB. These include eucapnic voluntary hyperpnea and osmotic stimuli (eg, inhaled mannitol) and offer improved diagnostic sensitivity to identify EIB and improved standardization when compared with laboratory exercise.

KW - Airway hyperresponsiveness

KW - Eucapnic voluntary hyperpnea

KW - Exercise-induced bronchoconstriction

KW - Mannitol

U2 - 10.1016/j.iac.2018.01.010

DO - 10.1016/j.iac.2018.01.010

M3 - Review

C2 - 29631731

AN - SCOPUS:85044975589

VL - 38

SP - 215

EP - 229

JO - Immunology and Allergy Clinics of North America

JF - Immunology and Allergy Clinics of North America

SN - 0889-8561

IS - 2

ER -

ID: 214688676